期刊文献+

质子泵抑制剂提高肿瘤化学治疗敏感性的研究进展 被引量:1

暂未订购
导出
摘要 恶性肿瘤对化学治疗药物产生耐药是肿瘤患者化学治疗失败的主要原因。肿瘤细胞外微环境高度酸化是肿瘤细胞对化学治疗药物产生耐药的机制之一。改变肿瘤细胞内外pH梯度是逆转耐药的一种有效方法。用于治疗酸相关疾病的质子泵抑制剂能通过抑制质子泵功能,改变胞内外pH梯度而阻断肿瘤微环境酸化,达到提高肿瘤对化学治疗药物敏感性的目的。此文就其在化学治疗增敏方面的研究进展作一综述。
作者 陈敏 邹晓平
出处 《国际消化病杂志》 CAS 2012年第1期50-53,共4页 International Journal of Digestive Diseases
基金 国家自然科学基金(81071816) 中央高校基本科研业务费苗圃项目(021414340018)
  • 相关文献

参考文献1

二级参考文献11

  • 1Quinn DA,Du HK,Thompson BT,et al.Amiloride analogs inhibit chronic hypoxic pulmonary hypertension.Am J Respir Crit Care Med,1998; 157(4 Pt 1):1263 -1268
  • 2Malinowska I,Stelmaszczyk-Emmel A,Wasik M,et al.Apoptosis and pH of blasts in acute childhood leukemia.Med Sci Monit,2002;8:CR441-447
  • 3Zhu WH,Loh TT.Effects of Na^+ /H^+ antiport and intracellular pH in the regulation of HL-60 cell apoptosis.Biochim Biophys Acta,1995; 1269:122-128
  • 4Larsen AK,Escargueil AE,Skladanowski A.Resistance mechanisms associated with altered intracellular distribution of anticancer agents.Pharmacol Ther,2000; 85:217-229
  • 5Wang E,Lee MD,Dunn KW.Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5uterine sarcoma cells.J Cell Physiol,2000; 184:263 -274
  • 6Weisburg JH,Curcio M,Caron PC,et al.The multidrug resistance phenotype confers immunological resistance.J Exp Med,1996;183:2699 -2704
  • 7Goossens JF,Henichart JP,Dassonneille L,et al.Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells.Eur J Pharm Sci,2000; 10:125 -313
  • 8Palissot V,Belhoussine R,Carpentier Y,et al.Resistance to apoptosis induced by topoisomerase I inhibitors in multidrug-resistant HL-60 leukemic cells.Biochem Biophys Res Commun,1998; 245:918-922
  • 9Vereninov AA,Vassilieva IO,Yurinskaya VE,et al.Differential transcription of ion transporters,NHE1,ATP1B1,NKCC1 in human peripheral blood lymphocytes activated to proliferation.Cell Physiol Biochem,2001; 11:19 -26
  • 10陈杰,钱桂生,黄桂君,熊玮,李靖.肺腺癌多药耐药细胞特异表达基因的克隆与鉴定[J].癌症,2001,20(4):348-353. 被引量:11

共引文献5

同被引文献16

  • 1Kyle GJ, Nissen LM ,Tett SE. The Australian rise of es- omeprazole-was expenditure on samples a contributor?[J]. Pharmacoepidemiol Drag Saf, 2009,18( 1 ) : 62-68.
  • 2Hollingworth S,Duncan EL,Martin JH. Marked increase in proton pump inhibitors use in australia[J]. Pharmacoepi- demiol Drug Saf, 2010, 19(10) : 1019-1024.
  • 3Schiller D, Maieron A, Schofl R, et al. Drug fever due to a single dose of pantoprazole[J]. Pharmacology, 2014,94 ( 1 - 2) :78-79.
  • 4Das S, Ganguly A, Ghosh A,et al. Oral pantoprazole-in- duced acute pancreatitis in an ll-year-old child[J]. Ther Drug Monit, 2012,34 (3) : 242-244.
  • 5Fracaroli TS, Miranda LQ, Sodre JL,et al. Toxic epider- mal necrolysis induced by lansoprazole[J]. An Bras Der- matol,2013,88(1) : 117-120.
  • 6Dunn SP,Steinhubl SR,Bauer D,et al. impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the caprie and credo trials[J]. J Am Heart Assoc,2013,2 ( 1 ) : e004564.
  • 7Leonard CE,Bilker WB,Brensinger CM,et al. Compara- tive risk of ischemic stroke among users of elopidogrel together with individual proton pump inhibitors[J]. Stroke, 2015,46(3) :722-731.
  • 8Tamura T,Sakaeda T,Kadoyama K,et al. Omeprazole- and esomeprazole -associated hypomagnesaemia: Data mining of the public version of the fda adverse event re- porting system[J]. Int J Med Sci, 2012,9 (5) : 322-326.
  • 9Singh V,Arora V,Alam MJ,et al. inhibition of biofilm formation by esomeprazole in pseudomonas aeruginosa and staphylococcus aureus[J]. Antimicrob Agents Chemoth- er, 2012,56(8) : 4360-4364.
  • 10何鑫,刘丽华,张明香,李柱,张莉.门诊质子泵抑制剂应用分析及合理性评价[J].临床合理用药杂志,2014,7(4):1-3. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部